Algeria vs Germany: Cause of death, by non-communicable diseases, ages 60+
Algeria
85.4%
in 2021
Germany
85.6%
in 2021
Algeria rank
18th
Germany rank
17th
Cause of death, by non-communicable diseases, ages 60+ over time
- Algeria
- Germany
How they compare
Germany currently reports 85.6% against 85.4% in Algeria, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Germany ahead.
Algeria ranks 18th and Germany ranks 17th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 1 and Germany in 2.
Head to head by decade
| Decade | Algeria | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.8% | 93.8% | 1.0% | Germany |
| 2010s | 93.1% | 92.1% | 1.1% | Algeria |
| 2020s | 78.9% | 86.9% | 8.0% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Algeria or Germany?
- Germany, at 85.6% against 85.4% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Algeria and Germany?
- 0.2%, with Germany ahead.
- How many years of comparable data are there for Algeria and Germany?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Germany rank globally for cause of death, by non-communicable diseases, ages 60+?
- Algeria ranks 18th and Germany ranks 17th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.